Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3465372rdf:typepubmed:Citationlld:pubmed
pubmed-article:3465372lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:3465372lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:3465372lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:3465372lifeskim:mentionsumls-concept:C0227525lld:lifeskim
pubmed-article:3465372lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:3465372lifeskim:mentionsumls-concept:C0033532lld:lifeskim
pubmed-article:3465372lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:3465372lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:3465372pubmed:issue3lld:pubmed
pubmed-article:3465372pubmed:dateCreated1987-1-9lld:pubmed
pubmed-article:3465372pubmed:abstractText3H-Labeled prostaglandins D2 and F2 alpha rapidly degraded to more-polar metabolites in primary cultured rat hepatocytes. The metabolites of prostaglandins D2 and F2 alpha accumulated in the culture medium. The metabolites extracted by ethyl acetate at pH 3 were purified by silicic acid column and thin-layer chromatography of silica gel, and were analysed by gas chromatography-mass spectrometry. The major metabolites from prostaglandin D2 were identified as dinor-prostaglandin D1 (7 alpha,13-dihydroxy-9-ketodinorprost-11-enoic acid) and tetranor-prostaglandin D1 (5 alpha,11- dihydroxy-7-ketotetranorprost-9-enoic acid). Those from prostaglandin F2 alpha were identified as dinor-prostaglandin F1 alpha (7 alpha,9 alpha,13-trihydroxydinorprost-11-enoic acid), tetranor-prostaglandin F1 alpha (5 alpha,7 alpha,11-trihydroxytetranorprost-9-enoic acid) and 9 alpha,11 alpha,15-trihydroxyprost-13-ene-1,20-dioic acid. These data indicate that prostaglandins D2 and F2 alpha mainly degraded by beta-oxidation, which is the same process as reported earlier for prostaglandins E1 and E2, and that prostaglandin F2 alpha was also subjected to omega-oxidation.lld:pubmed
pubmed-article:3465372pubmed:languageenglld:pubmed
pubmed-article:3465372pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3465372pubmed:citationSubsetIMlld:pubmed
pubmed-article:3465372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3465372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3465372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3465372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3465372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3465372pubmed:statusMEDLINElld:pubmed
pubmed-article:3465372pubmed:monthDeclld:pubmed
pubmed-article:3465372pubmed:issn0006-3002lld:pubmed
pubmed-article:3465372pubmed:authorpubmed-author:SaitoKKlld:pubmed
pubmed-article:3465372pubmed:authorpubmed-author:NakayamaRRlld:pubmed
pubmed-article:3465372pubmed:authorpubmed-author:OkumuraTTlld:pubmed
pubmed-article:3465372pubmed:authorpubmed-author:SagaJJlld:pubmed
pubmed-article:3465372pubmed:issnTypePrintlld:pubmed
pubmed-article:3465372pubmed:day5lld:pubmed
pubmed-article:3465372pubmed:volume879lld:pubmed
pubmed-article:3465372pubmed:ownerNLMlld:pubmed
pubmed-article:3465372pubmed:authorsCompleteYlld:pubmed
pubmed-article:3465372pubmed:pagination330-8lld:pubmed
pubmed-article:3465372pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:meshHeadingpubmed-meshheading:3465372-...lld:pubmed
pubmed-article:3465372pubmed:year1986lld:pubmed
pubmed-article:3465372pubmed:articleTitleMetabolism of prostaglandins D2 and F2 alpha in primary cultures of rat hepatocytes.lld:pubmed
pubmed-article:3465372pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3465372lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3465372lld:pubmed